Thirty-Day Outcomes of Transcatheter Mitral Valve Replacement for Degenerated Mitral Bioprostheses (Valve-in-Valve), Failed Surgical Rings (Valve-in-Ring), and Native Valve With Severe Mitral Annular Calcification (Valve-in-Mitral Annular Calcification) in the United States

Mayra Guerrero,Sreekanth Vemulapalli,Qun Xiang,Dee Dee Wang,Mackram F. Eleid,Allison K. Cabalka,Gurpreet S. Sandhu,Michael H. Salinger,Hyde M. Russell,Adam Greenbaum,Susheel Kodali,Isaac George,Danny Dvir,Brian Whisenant,Mark J Russo,Ashish Pershad,Kenith Fang,Megan Coylewright,Pinak B. Shah,Vasilis Babaliaros,Jaffar M Khan,Carl L. Tommaso,Jorge F. Saucedo,Saibal Kar,Rajj Makkar,Michael J. Mack,David R. Holmes,Martin B. Leon,Vinayak Bapat,Vinod H. Thourani,Charanjit S. Rihal,William O'Neill,Ted Feldman

Thirty-Day Outcomes of Transcatheter Mitral Valve Replacement for Degenerated Mitral Bioprostheses (Valve-in-Valve), Failed Surgical Rings (Valve-in-Ring), and Native Valve With Severe Mitral Annular Calcification (Valve-in-Mitral Annular Calcification) in the United States

2020

Background: Transcatheter mitral valve replacement using aortic transcatheter heart valves has recently become an alternative for patients with degenerated mitral bioprostheses, failed surgical rep...

Keywords:

Mitral valve
native valve
Medicine
Calcification
Mitral valve replacement
Cardiology
Internal medicine
THIRTY-DAY

Correction
Cite
Save
Machine Reading By IdeaReader

References

Citations